- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Breaking news: Aurobindo Pharma Director arrested in Delhi Excise Policy money laundering case

New Delhi: The whole-time director of pharma company Aurobindo Pharma, Sharath Chandra Reddy has recently been arrested by the Enforcement Directorate (ED) in Delhi Excise Policy 2021-22 money laundering case.As per the official website of Aurobindo Pharma Sharath Chandra Reddy, a graduate of Business Administration and is a second-generation entrepreneur belonging to the...
New Delhi: The whole-time director of pharma company Aurobindo Pharma, Sharath Chandra Reddy has recently been arrested by the Enforcement Directorate (ED) in Delhi Excise Policy 2021-22 money laundering case.
As per the official website of Aurobindo Pharma Sharath Chandra Reddy, a graduate of Business Administration and is a second-generation entrepreneur belonging to the promoter group.
The Enforcement Directorate has arrested two businessmen belonging to Andhra Pradesh and Telangana in the matter The businessmen have been identified as Sharath Chandra Reddy and Binoy Babu.
Read also: Money laundering case: Surya Pharma properties worth Rs 185 crore attached by ED
Aurobindo Pharma Limited is a global pharmaceutical company headquartered in Hyderabad, India. The Company develops, manufactures, and commercializes a wide range of generic pharmaceuticals, branded specialty pharmaceuticals, and active pharmaceutical ingredients globally in over 155 countries.
The company has 27 manufacturing and packaging facilities that are approved by leading regulatory agencies including USFDA, UK MHRA, EDQM, Japan PMDA, WHO, Health Canada, South Africa MCC, and Brazil ANVISA. The company's robust product portfolio is spread over 7 major therapeutic/product areas encompassing CNS, Anti-Retroviral, CVS, Antibiotics, Gastroenterological, Anti-Diabetics, and Anti-Allergic, supported by a strong R&D set-up.
M.Com
Ruchika joined Medical Dialogue as an Desk Editor for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751